LESA KLOZENBUCHER: Open Payments
NPI 1417923327 · HAYS, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$126 in 5 payments from 5 companies in 2025. Trend: 2023 $259 · 2024 $161 · 2025 $126
Food & beverage: $126
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 1 | $31 |
| GlaxoSmithKline, LLC. | 1 | $30 |
| GENZYME CORPORATION | 1 | $26 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Resmed Corp | 1 | $19 |
Products named: DUPIXENT, TRELEGY ELLIPTA, FASENRA, AIRSENSE.
Industry payments across KS — which companies pay providers there.
